Evidence map›Paper›PMID 22705044›Full record

ArticleActa biomaterialia2012

Differential functional effects of biomaterials on dendritic cell maturation.

Jaehyung Park, Julia E Babensee

Abstract read
In one paragraph

Article in Acta biomaterialia, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 151 citations in OpenAlex.

  1. Article
  2. Article
  3. Embroidered Silk Fibroin Scaffolds for ACL Tissue Engineering.International journal of molecular sciences · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Emerging strategies for nanomedicine in autoimmunity.Advanced drug delivery reviews · 2024
    Review
  8. Engineering metabolism to modulate immunity.Advanced drug delivery reviews · 2024
    Review
  9. Article
  10. Arthritic Microenvironment-Dictated Fate Decisions for Stem Cells in Cartilage Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jaehyung ParkWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.
Julia E Babensee
The Wallace H. Coulter Department of Biomedical Engineering · US

Funding

Dendritic cell phenotype upon contact with biomaterialsR01EB004633 · NIBIB · GEORGIA INSTITUTE OF TECHNOLOGY · PI BABENSEE, JULIA E · 2005 to 2008
$1.2M
NIBIB NIH HHS 1R01EB004633-01A1NIBIB NIH HHS R01 EB004633
6 · The paper itself

Abstract

The immunological outcome of dendritic cell (DC) treatment with different biomaterials was assessed to demonstrate the range of DC phenotypes induced by biomaterials commonly used in combination products. Immature DCs (iDCs) were derived from human peripheral blood monocytes, and treated with different biomaterial films of alginate, agarose, chitosan, hyaluronic acid (HA), or 75:25 poly(lactic-co-glycolic acid) (PLGA) and a comprehensive battery of phenotypic functional outcomes was assessed. Different levels of functional changes in DC phenotype were observed depending on the type of biomaterial films used to treat the DCs. Treatment of DCs with PLGA or chitosan films supported DC maturation, with higher levels of DC allostimulatory capacity, pro-inflammatory cytokine release, and expression of CD80, CD86, CD83, HLA-DQ and CD44 compared with iDCs, and lower endocytic ability compared with iDCs. Alginate film induced pro-inflammatory cytokine release from DCs at levels higher than from iDCs. Dendritic cells treated with HA film expressed lower levels of CD40, CD80, CD86 and HLA-DR compared with iDCs. They also exhibited lower endocytic ability and CD44 expression than iDCs, possibly due to an insolubilized (cross-linked) form of high molecular weight HA. Interestingly, treatment of DCs with agarose film maintained the DC functional phenotype at levels similar to iDCs except for CD44 expression, which was lower than that of iDCs. Taken together, these results can provide selection criteria for biomaterials to be used in immunomodulating applications and can inform potential outcomes of biomaterials within combination products on associated immune responses as desired by the application.

Indexed as

ApoptosisBiocompatible MaterialsCell AdhesionCell DifferentiationCell MovementCell ProliferationCell ShapeChitosanCytokinesDendritic CellsEndocytosisFlow CytometryFluorescenceHistocompatibility Antigens Class IIHumansHyaluronic AcidBiocompatible MaterialsChitosanCytokinesHistocompatibility Antigens Class IIHyaluronic AcidInflammation MediatorsLactic AcidLipopolysaccharidesPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerReceptors, Cell SurfaceSepharoseTranscription Factor RelA

Identifiers

PMID22705044
PMCPMC3970713
OpenAlexW2083429131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.